Omnicell

JANUARY 10, 2023

The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compounded sterile products (CSPs) and instead allow users of self-enclosed robotic devices to surface sample once per day.

Sterile Compounds 98

Sterile Compounds Compounding Omnicell Patient Care 98

Omnicell

JANUARY 10, 2023

Implementing an intelligent infrastructure of automation and intelligence, supported by expert services to ensure optimization, is an opportunity for health systems to enhance medication distribution processes, support sterile compounding safety and efficiency, and ultimately improve pharmacy supply chain management.

Sterile Compounds 97

Sterile Compounds Omnicell Compounding Hospitals 97

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

Studies have shown that one out of every ten can put patients at risk. Sterile compounding is also one of the costliest functions in pharmacy operations. Still, many hospital pharmacies continue to struggle to improve safety and efficiency in their sterile compounding operations. 5 at 2 p.m. EDT (11 a.m.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

By connecting medication inventory across the entire healthcare infrastructure and leveraging the data pulled from that technology, there is a huge opportunity to reduce instances of human error, improve efficiency, control costs, ensure compliance and, ultimately, enhance patient care and safety.

Hospitals 52

Hospitals Sterile Compounds Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

Overreliance on 503B facilities for sterile compounding led them to seek a solution that would reduce outsourcing costs and waste by better managing supply challenges through improved efficiency. Gee Mathen, Director of Pharmacy Clinical Applications and Technical Services, realized that technology alone wouldn't solve the issue.

Omnicell 52

Omnicell Sterile Compounds Compounding Hospitals 52

Omnicell

MARCH 27, 2023

BMHCC is simultaneously focused on the challenges of reducing acute care drug spend and improving their drug delivery model, with IV preparation and diversion detection as the chief drug delivery concerns. The goal is to move pharmacists and other clinicians to the center of patient care where they can practice at the top of their license.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52